CCN2 and Hepatic fibrosis: We also detected the effects of WM treatment on the expression of the following proteins: α-SMA, a critical marker of HSC activation [71]; CTGF, a maker of liver fibrosis [72, 73]; and integrin-β1, a hallmark of hepatic fibrosis [74].